How to Choose the Right CDMO
April 02, 2026
Your science is ready.
The mechanism is well-characterized, the preclinical data is compelling, and the clinical development...
Read more →In the first post in this series, we looked at the manufacturing landscape for advanced therapies and what the FDA data tells us about why CMC strategy is so consequential to...
Read More →April 02, 2026
Your science is ready.
The mechanism is well-characterized, the preclinical data is compelling, and the clinical development...
Read more →December 02, 2025
Advanced therapies present unique challenges from both a regulatory and a chemistry, manufacturing, and controls (CMC)...
Read more →